Breimer DD - Search Results

1

Impairment of phenytoin parahydroxylation as a cause of severe intoxication.

de Wolff FA, Vermeij P, Ferrari MD, Buruma OJ, Breimer DD. de Wolff FA, et al. Among authors: breimer dd. Ther Drug Monit. 1983 Jun;5(2):213-5. doi: 10.1097/00007691-198306000-00011. Ther Drug Monit. 1983. PMID: 6879646

2

Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.

Danhof M, Idle JR, Teunissen MW, Sloan TP, Breimer DD, Smith RL. Danhof M, et al. Among authors: breimer dd. Pharmacology. 1981;22(6):349-58. doi: 10.1159/000137515. Pharmacology. 1981. PMID: 7267701

3

Relationship between mephenytoin oxidation polymorphism and phenytoin, methylphenytoin and phenobarbitone hydroxylation assessed in a phenotyped panel of healthy subjects.

Schellens JH, van der Wart JH, Breimer DD. Schellens JH, et al. Among authors: breimer dd. Br J Clin Pharmacol. 1990 Jun;29(6):665-71. doi: 10.1111/j.1365-2125.1990.tb03687.x. Br J Clin Pharmacol. 1990. PMID: 2378787 Free PMC article.

4

Antipyrine metabolite formation in children in the acute phase of malnutrition and after recovery.

Buchanan N, Davis M, Danhof M, Breimer DD. Buchanan N, et al. Among authors: breimer dd. Br J Clin Pharmacol. 1980 Oct;10(4):363-8. doi: 10.1111/j.1365-2125.1980.tb01772.x. Br J Clin Pharmacol. 1980. PMID: 7448107 Free PMC article.

5

Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.

Danhof M, Breimer DD. Danhof M, et al. Among authors: breimer dd. Br J Clin Pharmacol. 1979 Dec;8(6):529-37. doi: 10.1111/j.1365-2125.1979.tb01040.x. Br J Clin Pharmacol. 1979. PMID: 533575 Free PMC article. Clinical Trial.

6

The disposition of antipyrine and its metabolites in young and elderly healthy volunteers.

Posner J, Danhof M, Teunissen MW, Breimer DD, Whiteman PD. Posner J, et al. Among authors: breimer dd. Br J Clin Pharmacol. 1987 Jul;24(1):51-5. doi: 10.1111/j.1365-2125.1987.tb03135.x. Br J Clin Pharmacol. 1987. PMID: 3620285 Free PMC article.

7

Antipyrine metabolite formation and excretion in patients with chronic renal failure.

Teunissen MW, Kampf D, Roots I, Vermeulen NP, Breimer DD. Teunissen MW, et al. Among authors: breimer dd. Eur J Clin Pharmacol. 1985;28(5):589-95. doi: 10.1007/BF00544072. Eur J Clin Pharmacol. 1985. PMID: 4043202

8

Antipyrine clearance and metabolite formation in children with congenital adrenal hyperplasia.

Teunissen MW, Bruining GJ, De Jongh BM, Tenkate-Westerhof EW, Breimer DD. Teunissen MW, et al. Among authors: breimer dd. Br J Clin Pharmacol. 1985 Dec;20(6):703-6. doi: 10.1111/j.1365-2125.1985.tb05134.x. Br J Clin Pharmacol. 1985. PMID: 4092001 Free PMC article.

9

Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.

Teunissen MW, van der Veen EA, Doodeman PJ, Breimer DD. Teunissen MW, et al. Among authors: breimer dd. Eur J Clin Pharmacol. 1984;27(1):99-103. Eur J Clin Pharmacol. 1984. PMID: 6489432

10

Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis.

Teunissen MW, Bakker W, Meerburg-Van der Torren JE, Breimer DD. Teunissen MW, et al. Among authors: breimer dd. Br J Clin Pharmacol. 1984 Nov;18(5):701-6. doi: 10.1111/j.1365-2125.1984.tb02532.x. Br J Clin Pharmacol. 1984. PMID: 6508979 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

366 results

Search Page

Filters